Arnold Lippa

Arnold Lippa

Company: RespireRx Pharmaceuticals Inc

Job title: Exec. Chairman, Chief Executive Officer and Chief Scientific Officer


Pharmaceutical Cannabinoids: A Company Update 2:00 pm

Examine re-purposing of dronabinol for the treatment of obstructive sleep apnea (OSA) and other indications Explore completion of two successful Phase 2 clinical trials in OSA Develop lipid nanoparticle formulation to overcome current dronabinol limitationsRead more

day: Day One Track A - afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.